Validation of LOH profiles for assessing oral cancer risk

Cancer Prevention Research

Volumn 5, Issue 9, 2012, Pages 1075-1077

  Lingen, Mark W ^a   Szabo, Eva ^b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CANCER GROWTH; CANCER INVASION; CANCER RISK; CLINICAL TRIAL (TOPIC); DYSPLASIA; HEAD AND NECK CARCINOMA; HETEROZYGOSITY LOSS; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; MOUTH CANCER; PRIORITY JOURNAL; SHORT SURVEY; SQUAMOUS CELL CARCINOMA;

FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS;

EID: 84866178802     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-12-0294     Document Type: Short Survey

References (28)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988;48:3282-7.
3. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008;26:612-9. (Pubitemid 351264356)
4. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008;100:407-20. (Pubitemid 351480511)
5. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-20. (Pubitemid 30365531)
6. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, KochWM,et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-56. (Pubitemid 46740304)
7. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Forastiere A, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100:261-9. (Pubitemid 351480538)
8. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Ngyuyen-Tan PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24-35.
9. Lippman SM, Hong WK. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 1989;17:691-4.
10. Rennemo E, Zatterstrom U, Boysen M. Impact of second primary tumors on survival in head and neck cancer: an analysis of 2,063 cases. Laryngoscope 2008;118:1350-6.
11. The National Lung Screening Trial Research Team Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Eng J Med 2001;365:395-409.
12. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, et al. Colorectal-cancer incidence and mortality with flexible screening sigmoidoscopy. N Eng J Med 2012;366:2345-57.
13. Abbey LM, Kaugars GE, Gunsolley JC, Burns JC, Page DG, Svirsky JA, et al. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;80:188-91.
14. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 2008;37:127-33. (Pubitemid 351178405)
15. Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long term treatment outcome of oral premalignant lesions. Oral Oncol 2006;42:461-74.
16. Arduino PG, Surace A, Carbone M, Elia A, Massolini G, Gandolfo S, et al. Outcome of oral dysplasia: a retrospective hospital-based study of 207patients with a long follow-up. J Oral Pathol Med 2009;38:540-4.
17. Mehanna HM, Rattay T, Smith J, McConkey CC. Treatment and follow-up of oral dysplasia-a systematic review and meta-analysis. Head Neck 2009;31:1600-9.
18. Saintigny P, Zhang L, Fan YH, El-Naggar AK, Papadimitrakopoulou VA, Feng L, et al. Gene expression profiling predicts the development of oral cancer. Cancer Prev Res 2011;4:218-29.
19. Benchedroun MT, Saintigny P, Thomas SM, El-Naggar AK, Papadimitrakopoulou V, Ren H, et al. Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer. Cancer Prev Res 2010;3:800-9.
20. Tsui IF, Rosin MP, Zhang L, Ng RT, Lam WL. Multiple aberrations of chromosome 3p detected in oral premalignant lesions. Cancer Prev Res 2008;1:424-9.
21. Zhang L, Williams M, Poh CF, Laronde D, Epstein JB, Durham S, et al. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res 2005;65:8017-21. (Pubitemid 41297282)
22. Garnis C, Baldwin C, Zhang L, Rosin MP, Lam WL. Use of complete coverage array comparative genomic hybridization to define copy number alterations on chromosome 3p in oral squamous cell carcinomas. Cancer Res 2003;63:8582-5. (Pubitemid 38064029)
23. Rosin MP, Lam WL, Poh C, Le ND, Li RZ, Zeng T, et al. 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites. Cancer Res 2002;62:6447-50. (Pubitemid 35364104)
24. Lee JJ, Hong WK, Hittelman WN, Mao L, Lotan R, Shin DM, et al. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res 2000;6:1702-10. (Pubitemid 30305062)
25. Rosin MP, Cheng X, Poh C, Lam WL, Huang Y, Lovas J, et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 2000;6:357-62. (Pubitemid 30111451)
26. Roz L, Wu CL, Porter S, Scully C, Speight P, Read A, et al. Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis. Cancer Res 1996;56:1228-31. (Pubitemid 26080959)
27. Ishwad CS, Ferrell RE, Rossie KN, Appel BN, Johnson JT, Myers EN, et al. Loss of heterozygosity of the short arm of chromosomes 3 and 9 in oral cancer. Int J Cancer 1996;69:1-4. (Pubitemid 26083262)
28. Zhang L, Poh CF, Williams M, Laronde DM, Berean K, Gardner PJ, et al. Loss of heterozygosity (LOH) profiles-validated risk predictors for progression to oral cancer. Cancer Prev Res 2012;5:1081-9.